Himly M - Search Results

1

Antiviral Activity of Zinc Oxide Nanoparticles against SARS-CoV-2.

Wolfgruber S, Rieger J, Cardozo O, Punz B, Himly M, Stingl A, Farias PMA, Abuja PM, Zatloukal K. Wolfgruber S, et al. Among authors: himly m. Int J Mol Sci. 2023 May 8;24(9):8425. doi: 10.3390/ijms24098425. Int J Mol Sci. 2023. PMID: 37176131 Free PMC article.

2

(Re)Conceptualizing decision-making tools in a risk governance framework for emerging technologies-the case of nanomaterials.

Mullins M, Himly M, Llopis IR, Furxhi I, Hofer S, Hofstätter N, Wick P, Romeo D, Küehnel D, Siivola K, Catalán J, Hund-Rinke K, Xiarchos I, Linehan S, Schuurbiers D, Bilbao AG, Barruetabeña L, Drobne D. Mullins M, et al. Among authors: himly m. Environ Syst Decis. 2023;43(1):3-15. doi: 10.1007/s10669-022-09870-2. Epub 2022 Jul 24. Environ Syst Decis. 2023. PMID: 35912374 Free PMC article. Review.

3

Traces of pFc' in IVIG interact with human IgG Fc domains and counteract aggregation.

Rispens T, Himly M, Ooievaar-De Heer P, den Bleker TH, Aalberse RC. Rispens T, et al. Among authors: himly m. Eur J Pharm Sci. 2010 Apr 16;40(1):62-8. doi: 10.1016/j.ejps.2010.03.001. Epub 2010 Mar 6. Eur J Pharm Sci. 2010. PMID: 20211252

4

Physicochemical and biological characterization of 1E10 anti-idiotype vaccine.

Machado YJ, Rabasa Y, Montesinos R, Cremata J, Besada V, Fuentes D, Castillo A, de la Luz KR, Vázquez AM, Himly M. Machado YJ, et al. Among authors: himly m. BMC Biotechnol. 2011 Nov 22;11:112. doi: 10.1186/1472-6750-11-112. BMC Biotechnol. 2011. PMID: 22108317 Free PMC article.

5

Glutaraldehyde-Modified Recombinant Fel d 1: A Hypoallergen With Negligible Biological Activity But Retained Immunogenicity.

Versteeg SA, Bulder I, Himly M, van Capel TM, van den Hout R, Koppelman SJ, de Jong EC, Ferreira F, van Ree R. Versteeg SA, et al. Among authors: himly m. World Allergy Organ J. 2011 Jul;4(7):113-9. doi: 10.1097/WOX.0b013e3182228a39. Epub 2011 Jul 14. World Allergy Organ J. 2011. PMID: 23268458 Free PMC article.

6

Defective vaccinia virus as a biologically safe tool for the overproduction of recombinant human secretory proteins.

Himly M, Pfleiderer M, Holzer G, Fischer U, Hannak E, Falkner FG, Dorner F. Himly M, et al. Protein Expr Purif. 1998 Dec;14(3):317-26. doi: 10.1006/prep.1998.0970. Protein Expr Purif. 1998. PMID: 9882565

7

Characterization of allergoids.

Himly M, Carnés J, Fernández-Caldas E, Briza P, Ferreira F. Himly M, et al. Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess. 2009;96:61-9; discussion 69-70. Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess. 2009. PMID: 20799446

8

The catalytic subunit of phosphoinositide 3-kinase: requirements for oncogenicity.

Aoki M, Schetter C, Himly M, Batista O, Chang HW, Vogt PK. Aoki M, et al. Among authors: himly m. J Biol Chem. 2000 Mar 3;275(9):6267-75. doi: 10.1074/jbc.275.9.6267. J Biol Chem. 2000. PMID: 10692423 Free article.

9

T Cell Epitope-Containing Domains of Ragweed Amb a 1 and Mugwort Art v 6 Modulate Immunologic Responses in Humans and Mice.

Sancho AI, Wallner M, Hauser M, Nagl B, Himly M, Asam C, Ebner C, Jahn-Schmid B, Bohle B, Ferreira F. Sancho AI, et al. Among authors: himly m. PLoS One. 2017 Jan 12;12(1):e0169784. doi: 10.1371/journal.pone.0169784. eCollection 2017. PLoS One. 2017. PMID: 28081194 Free PMC article.

10

Basophil Reactivity as Biomarker in Immediate Drug Hypersensitivity Reactions-Potential and Limitations.

Steiner M, Harrer A, Himly M. Steiner M, et al. Among authors: himly m. Front Pharmacol. 2016 Jun 17;7:171. doi: 10.3389/fphar.2016.00171. eCollection 2016. Front Pharmacol. 2016. PMID: 27378928 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

95 results

Search Page